The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Ipsen
Stock and Other Ownership Interests - Pfizer

Lanreotide for the prolonged control of carcinoid syndrome (CS) in somatostatin analog (SSA)-naïve or experienced patients.
 
Edward M. Wolin
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Lexicon; Novartis
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Merck, Genentech, Ipsen
Consulting or Advisory Role - Celgene; ipsen
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); EpicentRx (Inst); Forty seven (Inst); Genentech/Roche (Inst); Ipsen (Inst); Merck (Inst); Newlink Genetics (Inst); Pharmaceutical Research Associates (Inst); Polaris (Inst); Sun Pharma (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Merck
 
Nilani Liyanage
Employment - Ipsen
Stock and Other Ownership Interests - Ipsen
 
Susan Pitman-Lowenthal
No Relationships to Disclose
 
Beloo Mirakhur
Employment - Ipsen
Stock and Other Ownership Interests - Ipsen
 
Rodney F. Pommier
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Novartis
 
Montaser F. Shaheen
No Relationships to Disclose
 
Aaron Vinik
Consulting or Advisory Role - Alnylam; Astellas Pharma; Ipsen; Janssen; Merck; Pamlab; VeroScience
Speakers' Bureau - Lexicon; Merck
Research Funding - Impeto Medical (Inst); Novo Nordisk (Inst); VeroScience (Inst); ViroMed (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen; Merck; Pamlab; Pfizer; Regeneron; VeroScience